BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 25322691)

  • 1. AKT1 and MYC induce distinctive metabolic fingerprints in human prostate cancer.
    Priolo C; Pyne S; Rose J; Regan ER; Zadra G; Photopoulos C; Cacciatore S; Schultz D; Scaglia N; McDunn J; De Marzo AM; Loda M
    Cancer Res; 2014 Dec; 74(24):7198-204. PubMed ID: 25322691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between bivariate expression of key oncogenes and metabolic phenotypes of patients with prostate cancer.
    Khodayari Moez E; Pyne S; Dinu I
    Comput Biol Med; 2018 Dec; 103():55-63. PubMed ID: 30340213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caveolin-1 upregulation contributes to c-Myc-induced high-grade prostatic intraepithelial neoplasia and prostate cancer.
    Yang G; Goltsov AA; Ren C; Kurosaka S; Edamura K; Logothetis R; DeMayo FJ; Troncoso P; Blando J; DiGiovanni J; Thompson TC
    Mol Cancer Res; 2012 Feb; 10(2):218-29. PubMed ID: 22144662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of Nkx3.1 leads to the activation of discrete downstream target genes during prostate tumorigenesis.
    Song H; Zhang B; Watson MA; Humphrey PA; Lim H; Milbrandt J
    Oncogene; 2009 Sep; 28(37):3307-19. PubMed ID: 19597465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells.
    Lee JK; Phillips JW; Smith BA; Park JW; Stoyanova T; McCaffrey EF; Baertsch R; Sokolov A; Meyerowitz JG; Mathis C; Cheng D; Stuart JM; Shokat KM; Gustafson WC; Huang J; Witte ON
    Cancer Cell; 2016 Apr; 29(4):536-547. PubMed ID: 27050099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined MYC Activation and Pten Loss Are Sufficient to Create Genomic Instability and Lethal Metastatic Prostate Cancer.
    Hubbard GK; Mutton LN; Khalili M; McMullin RP; Hicks JL; Bianchi-Frias D; Horn LA; Kulac I; Moubarek MS; Nelson PS; Yegnasubramanian S; De Marzo AM; Bieberich CJ
    Cancer Res; 2016 Jan; 76(2):283-92. PubMed ID: 26554830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MYC cooperates with AKT in prostate tumorigenesis and alters sensitivity to mTOR inhibitors.
    Clegg NJ; Couto SS; Wongvipat J; Hieronymus H; Carver BS; Taylor BS; Ellwood-Yen K; Gerald WL; Sander C; Sawyers CL
    PLoS One; 2011 Mar; 6(3):e17449. PubMed ID: 21394210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate epithelial cell of origin determines cancer differentiation state in an organoid transformation assay.
    Park JW; Lee JK; Phillips JW; Huang P; Cheng D; Huang J; Witte ON
    Proc Natl Acad Sci U S A; 2016 Apr; 113(16):4482-7. PubMed ID: 27044116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GLIPR1 suppresses prostate cancer development through targeted oncoprotein destruction.
    Li L; Ren C; Yang G; Fattah EA; Goltsov AA; Kim SM; Lee JS; Park S; Demayo FJ; Ittmann MM; Troncoso P; Thompson TC
    Cancer Res; 2011 Dec; 71(24):7694-704. PubMed ID: 22025562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nkx3.1 and Myc crossregulate shared target genes in mouse and human prostate tumorigenesis.
    Anderson PD; McKissic SA; Logan M; Roh M; Franco OE; Wang J; Doubinskaia I; van der Meer R; Hayward SW; Eischen CM; Eltoum IE; Abdulkadir SA
    J Clin Invest; 2012 May; 122(5):1907-19. PubMed ID: 22484818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel metabolic function of Myc in regulation of fatty acid synthesis in prostate cancer.
    Singh KB; Hahm ER; Kim SH; Wendell SG; Singh SV
    Oncogene; 2021 Jan; 40(3):592-602. PubMed ID: 33199826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MYC Mediates Large Oncosome-Induced Fibroblast Reprogramming in Prostate Cancer.
    Minciacchi VR; Spinelli C; Reis-Sobreiro M; Cavallini L; You S; Zandian M; Li X; Mishra R; Chiarugi P; Adam RM; Posadas EM; Viglietto G; Freeman MR; Cocucci E; Bhowmick NA; Di Vizio D
    Cancer Res; 2017 May; 77(9):2306-2317. PubMed ID: 28202510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate-specific oncogene OTUD6A promotes prostatic tumorigenesis via deubiquitinating and stabilizing c-Myc.
    Peng Y; Liu J; Wang Z; Cui C; Zhang T; Zhang S; Gao P; Hou Z; Liu H; Guo J; Zhang J; Wen Y; Wei W; Zhang L; Liu J; Long J
    Cell Death Differ; 2022 Sep; 29(9):1730-1743. PubMed ID: 35217790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity.
    Kim J; Roh M; Abdulkadir SA
    BMC Cancer; 2010 Jun; 10():248. PubMed ID: 20515470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between cells with distinct mutations in c-MYC and Pten in prostate cancer.
    Kim J; Eltoum IE; Roh M; Wang J; Abdulkadir SA
    PLoS Genet; 2009 Jul; 5(7):e1000542. PubMed ID: 19578399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A long noncoding RNA connects c-Myc to tumor metabolism.
    Hung CL; Wang LY; Yu YL; Chen HW; Srivastava S; Petrovics G; Kung HJ
    Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18697-702. PubMed ID: 25512540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. O-GlcNAc transferase integrates metabolic pathways to regulate the stability of c-MYC in human prostate cancer cells.
    Itkonen HM; Minner S; Guldvik IJ; Sandmann MJ; Tsourlakis MC; Berge V; Svindland A; Schlomm T; Mills IG
    Cancer Res; 2013 Aug; 73(16):5277-87. PubMed ID: 23720054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent nuclear ERG and MYC protein overexpression defines a subset of locally advanced prostate cancer: Potential opportunities for synergistic targeted therapeutics.
    Udager AM; DeMarzo AM; Shi Y; Hicks JL; Cao X; Siddiqui J; Jiang H; Chinnaiyan AM; Mehra R
    Prostate; 2016 Jun; 76(9):845-53. PubMed ID: 27159573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unopposed c-MYC expression in benign prostatic epithelium causes a cancer phenotype.
    Williams K; Fernandez S; Stien X; Ishii K; Love HD; Lau YF; Roberts RL; Hayward SW
    Prostate; 2005 Jun; 63(4):369-84. PubMed ID: 15937962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MYC overexpression induces prostatic intraepithelial neoplasia and loss of Nkx3.1 in mouse luminal epithelial cells.
    Iwata T; Schultz D; Hicks J; Hubbard GK; Mutton LN; Lotan TL; Bethel C; Lotz MT; Yegnasubramanian S; Nelson WG; Dang CV; Xu M; Anele U; Koh CM; Bieberich CJ; De Marzo AM
    PLoS One; 2010 Feb; 5(2):e9427. PubMed ID: 20195545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.